We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence of Ocular Surface Disease in Glaucoma Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00382122
First Posted: September 28, 2006
Last Update Posted: May 28, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Alcon Research
September 27, 2006
September 28, 2006
May 28, 2012
September 2006
February 2007   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00382122 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Prevalence of Ocular Surface Disease in Glaucoma Patients
Prevalence of Ocular Surface Disease in Glaucoma Patients
Demographic information and a brief medical and concomitant medicine history will be obtained from the glaucoma patient's records. Qualified patients will be asked to complete a questionnaire about their symptoms. Patients will then be scheduled to undergo three standard clinical tests of the ocular surface.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample
Patients 18 years or older with open-angle glaucoma or ocular hypertension were consecutively recruited for the study.
Glaucoma
Not Provided
Not Provided
Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma. 2008 Aug;17(5):350-5. doi: 10.1097/IJG.0b013e31815c5f4f.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
101
February 2007
February 2007   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of glaucoma;
  • Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

  • Inability to understand trial procedures;
  • Inability to understand Informed Consent;
  • Current use or use within the last 3 months of Restasis, steroids, or topical ocular non-steroidal anti-inflammatory drugs;
  • Punctal plugs;
  • Previous glaucoma, corneal, or conjunctival surgery;
  • Other protocol-defined exclusion criteria may apply.
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00382122
CMS-06-06
Not Provided
Not Provided
Not Provided
Alcon Research
Alcon Research
Not Provided
Study Director: Felipe Medeiros, MD, PhD University of California, San Diego
Alcon Research
September 2007